(Q44199951)

30 November 2017

title

High frequency and reduced penetrance of LRRK2 G2019S mutation among Parkinson's disease patients in Cantabria (Spain). (English)

1 reference

30 November 2017

1 reference

María Sierra

1

1 reference

30 November 2017

Isabel González-Aramburu

2

1 reference

30 November 2017

Pascual Sánchez-Juan

3

1 reference

30 November 2017

Coro Sánchez-Quintana

4

1 reference

30 November 2017

José Miguel Polo

5

1 reference

30 November 2017

José Berciano

6

1 reference

30 November 2017

Onofre Combarros

7

1 reference

30 November 2017

Jon Infante

8

1 reference

30 November 2017

language of work or name

English

0 references

publication date

27 September 2011

1 reference

30 November 2017

1 reference

30 November 2017

volume

26

1 reference

30 November 2017

issue

13

1 reference

30 November 2017

page(s)

2343-2346

1 reference

LRRK2 and Parkinson disease

30 November 2017

cites work

1 reference

Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review.

21 January 2018

1 reference

The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews

21 January 2018

1 reference

LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago.

21 January 2018

1 reference

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations

21 January 2018

1 reference

G2019S LRRK2 mutation in French and North African families with Parkinson's disease

21 January 2018

1 reference

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

21 January 2018

1 reference

The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study

21 January 2018

1 reference

LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.

21 January 2018

1 reference

Frequency of LRRK2 mutations in early- and late-onset Parkinson disease

21 January 2018

1 reference

Low disease risk in relatives of north african lrrk2 Parkinson disease patients

21 January 2018

1 reference

Two-sided confidence intervals for the single proportion: comparison of seven methods

21 January 2018

1 reference

Probable Inference, the Law of Succession, and Statistical Inference

21 January 2018

1 reference

LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance

21 January 2018

1 reference

LRRK2 G2019S and R1441G mutations associated with Parkinson's disease are common in the Basque Country, but relative prevalence is determined by ethnicity.

21 January 2018

1 reference

Prevalence and clinical features of LRRK2 mutations in patients with Parkinson's disease in southern Spain

21 January 2018

1 reference

High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal

21 January 2018

1 reference

Test for LRRK2 mutations in patients with Parkinson's disease.

21 January 2018

1 reference

LRRK2 mutations are a common cause of Parkinson's disease in Spain

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.23965

1 reference

30 November 2017

1 reference